-
1
-
-
18244381562
-
Acetylcholinesterase and butyrylcholinesterase
-
Important enzymes of human body
-
Patocka J, Kuca K, Jun D. Acetylcholinesterase and butyrylcholinesterase. Important enzymes of human body. Acta Med (Hradec Králové) 2004; 47: 215-28.
-
(2004)
Acta Med (Hradec Králové)
, vol.47
, pp. 215-228
-
-
Patocka, J.1
Kuca, K.2
Jun, D.3
-
2
-
-
0001986563
-
Enzyme tests in hepatobiliary disease
-
In: Moss DW, Rosalki SB (eds.), London: Arnold
-
Nemesánszky E. Enzyme tests in hepatobiliary disease. In: Moss DW, Rosalki SB (eds.). Enzyme Tests in Diagnosis. London: Arnold; 1996: 25-59.
-
(1996)
Enzyme Tests in Diagnosis
, pp. 25-59
-
-
Nemesánszky, E.1
-
3
-
-
4143050687
-
Enzymes
-
In: Burtis CA, Ashwood ER (eds.), 5th. Ed. Philadelphia: W.B. Saunders Company
-
Henderson AR, Moss DW. Enzymes. In: Burtis CA, Ashwood ER (eds.). Tietz Fundamentals of Clinical Chemistry. 5th. Ed. Philadelphia: W.B. Saunders Company; 2001, p. 352-89.
-
(2001)
Tietz Fundamentals of Clinical Chemistry
, pp. 352-389
-
-
Henderson, A.R.1
Moss, D.W.2
-
4
-
-
66149103723
-
Cholinergic control of inflammation
-
Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med 2009; 265: 663-79.
-
(2009)
J Intern Med
, vol.265
, pp. 663-679
-
-
Rosas-Ballina, M.1
Tracey, K.J.2
-
5
-
-
37249057800
-
Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation
-
Das UN. Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation. Med Sci Monit 2007; 13: RA214-RA221.
-
(2007)
Med Sci Monit
, vol.13
-
-
Das, U.N.1
-
6
-
-
35448954937
-
Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease
-
Rao AA, Sridhar GR, Das UN. Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease. Med Hypotheses 2007; 69: 1272-6.
-
(2007)
Med Hypotheses
, vol.69
, pp. 1272-1276
-
-
Rao, A.A.1
Sridhar, G.R.2
Das, U.N.3
-
7
-
-
55249099305
-
Enhanced butyrylcholinesterase activity may be the common link triggering low-grade systemic inflammation and decrease in cognitive function in diabetes mellitus and Alzheimer's disease
-
Rao AA, Reddy CS, Sridhar GR, Annapurna A, Hanuman T, Pramela M, et al. Enhanced butyrylcholinesterase activity may be the common link triggering low-grade systemic inflammation and decrease in cognitive function in diabetes mellitus and Alzheimer's disease. Current Nutr Food Sci 2008; 4: 213-6.
-
(2008)
Current Nutr Food Sci
, vol.4
, pp. 213-216
-
-
Rao, A.A.1
Reddy, C.S.2
Sridhar, G.R.3
Annapurna, A.4
Hanuman, T.5
Pramela, M.6
-
8
-
-
77955493261
-
Butyrylcholinesterase activity in multiple sclerosis neuropathology
-
Darvesh S, LeBlanc AM, Macdonald IR, Reid GA, Bhan V, Macaulay RJ, Fisk JD. Butyrylcholinesterase activity in multiple sclerosis neuropathology. Chem Biol Interact 2010; 187: 425-31.
-
(2010)
Chem Biol Interact
, vol.187
, pp. 425-431
-
-
Darvesh, S.1
Leblanc, A.M.2
Macdonald, I.R.3
Reid, G.A.4
Bhan, V.5
Macaulay, R.J.6
Fisk, J.D.7
-
9
-
-
15744378528
-
Evolution of C-reactive protein as a cardiac risk factor
-
D'Amore PJ. Evolution of C-reactive protein as a cardiac risk factor. Labmedicine 2005; 36: 234-8.
-
(2005)
Labmedicine
, vol.36
, pp. 234-238
-
-
D'Amore, P.J.1
-
10
-
-
0034604248
-
Chronic subclinical inflammation as part of the insulin resistance syndrome
-
Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome. Circulation 2000; 102: 42-7.
-
(2000)
Circulation
, vol.102
, pp. 42-47
-
-
Festa, A.1
D'Agostino, R.2
Howard, G.3
Mykkänen, L.4
Tracy, R.P.5
Haffner, S.M.6
-
11
-
-
0037469177
-
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
-
Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107; 363-9.
-
(2003)
Circulation
, vol.107
, pp. 363-369
-
-
Ridker, P.M.1
-
12
-
-
77958477932
-
Butyrylcholinesterase in metabolic syndrome
-
Sridhar GR, Rao AA, Srinavas K, Nirmala G, Lakshmi G, Suryanarayna D, et al. Butyrylcholinesterase in metabolic syndrome. Med Hypotheses 2010; 75: 648-54.
-
(2010)
Med Hypotheses
, vol.75
, pp. 648-654
-
-
Sridhar, G.R.1
Rao, A.A.2
Srinavas, K.3
Nirmala, G.4
Lakshmi, G.5
Suryanarayna, D.6
-
13
-
-
23244450772
-
Relationship between butyrylcholinesterase and the metabolic syndrome
-
Randell EW, Mathews MS, Zhang H, Seraj JS, Sun G. Relationship between butyrylcholinesterase and the metabolic syndrome. Clin Biochem 2005; 38: 799-805.
-
(2005)
Clin Biochem
, vol.38
, pp. 799-805
-
-
Randell, E.W.1
Mathews, M.S.2
Zhang, H.3
Seraj, J.S.4
Sun, G.5
-
14
-
-
79955835076
-
Butyrylcholinesterase activity in young and women: Association with cardiovascular risk factors
-
Stojanov M, Stefanovic A, Dzingalasevic G, Mandic-Radic S, Prostran M. Butyrylcholinesterase activity in young and women: Association with cardiovascular risk factors. Clin Biochem 2011; 44: 623-6.
-
(2011)
Clin Biochem
, vol.44
, pp. 623-626
-
-
Stojanov, M.1
Stefanovic, A.2
Dzingalasevic, G.3
Mandic-Radic, S.4
Prostran, M.5
-
15
-
-
34249290031
-
C-reactive protein: A pentraxin with antiacethylcholine activity
-
Nazarov PG, Krylova IB, Evdokimova NR, Nezhinskaya GI, Butyugov AA. C-reactive protein: a pentraxin with antiacethylcholine activity. Life Sci 2007; 80: 2337-41.
-
(2007)
Life Sci
, vol.80
, pp. 2337-2341
-
-
Nazarov, P.G.1
Krylova, I.B.2
Evdokimova, N.R.3
Nezhinskaya, G.I.4
Butyugov, A.A.5
-
16
-
-
0042265556
-
A simple noninvasive index can predict fibrosis and cirrhosis in patients with chronic hepatitis C
-
Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-26.
-
(2003)
Hepatology
, vol.38
, pp. 518-526
-
-
Wai, C.T.1
Greenson, J.K.2
Fontana, R.J.3
Kalbfleisch, J.D.4
Marrero, J.A.5
Conjeevaram, H.S.6
-
17
-
-
33646113599
-
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values
-
Fabris C, Smirne C, Toniutto P, Coletta C, Rapetti R, Minisini T, et al. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values. Clin Biochem 2006; 39: 339-43.
-
(2006)
Clin Biochem
, vol.39
, pp. 339-343
-
-
Fabris, C.1
Smirne, C.2
Toniutto, P.3
Coletta, C.4
Rapetti, R.5
Minisini, T.6
-
18
-
-
85009010955
-
AHA/CDC scientific statement on markers of inflammation and cardiovascular disease
-
AHA/CDC scientific statement on markers of inflammation and cardiovascular disease. Circulation 2003; 107: 499-511.
-
(2003)
Circulation
, vol.107
, pp. 499-511
-
-
-
19
-
-
79952111980
-
Establishing indicators for diagnosis of cholinergic crisis [article in Japanese]
-
Kariyone K, Shimatani Y, Kurihara T, Nagao T, Fujita Y, Uesegui M. Establishing indicators for diagnosis of cholinergic crisis [article in Japanese]. Rinsho Byori 2010; 58: 972-78.
-
(2010)
Rinsho Byori
, vol.58
, pp. 972-978
-
-
Kariyone, K.1
Shimatani, Y.2
Kurihara, T.3
Nagao, T.4
Fujita, Y.5
Uesegui, M.6
-
21
-
-
27544478172
-
Butyrylcoholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in plasma
-
Li B, Sedlacek M, Manohoran I, Boopathy R, Duysen EG, Masson P, et al. Butyrylcoholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in plasma. Biochem Pharmacol 2005; 70: 1673-84.
-
(2005)
Biochem Pharmacol
, vol.70
, pp. 1673-1684
-
-
Li, B.1
Sedlacek, M.2
Manohoran, I.3
Boopathy, R.4
Duysen, E.G.5
Masson, P.6
-
22
-
-
57649115640
-
Butyrylcholinesterase activity and mortality risk in hemodialysis patients: Comparison to hs- CRP and albumin
-
Stojanov MD, Jovicic DM, Djuric SP, Konjevic MM, Todorovic ZM, Prostran MS. Butyrylcholinesterase activity and mortality risk in hemodialysis patients: Comparison to hs- CRP and albumin. Clin Biochem 2009; 42: 22-6.
-
(2009)
Clin Biochem
, vol.42
, pp. 22-26
-
-
Stojanov, M.D.1
Jovicic, D.M.2
Djuric, S.P.3
Konjevic, M.M.4
Todorovic, Z.M.5
Prostran, M.S.6
-
23
-
-
33646336909
-
Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem
-
Calderon-Margalit R, Adler B, Abramson JH, Gofin J, Kark JD. Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem. Clin Chem 2006; 52: 845-52.
-
(2006)
Clin Chem
, vol.52
, pp. 845-852
-
-
Calderon-Margalit, R.1
Adler, B.2
Abramson, J.H.3
Gofin, J.4
Kark, J.D.5
-
24
-
-
0010492111
-
Enzyme tests in renal and urinary disease
-
In: Doss DW, Rosalki SB, (eds.), London: Arnold
-
Jung K. Enzyme tests in renal and urinary disease. In: Doss DW, Rosalki SB, (eds.). Enzyme Tests in Diagnosis. London: Arnold; 1996, p. 215-60.
-
(1996)
Enzyme Tests in Diagnosis
, pp. 215-260
-
-
Jung, K.1
-
25
-
-
35448939247
-
Cholinergic status modulations in human volunteers under acute inflammation
-
Ofek K, Krabbe KS. Evron T, Debbecco M, Nielsen AR, Brunnsgaad H, et al. Cholinergic status modulations in human volunteers under acute inflammation. J Mol Med 2007; 85: 1239-51.
-
(2007)
J Mol Med
, vol.85
, pp. 1239-1251
-
-
Ofek, K.1
Krabbe, K.S.2
Evron, T.3
Debbecco, M.4
Nielsen, A.R.5
Brunnsgaad, H.6
-
26
-
-
77954254517
-
Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality
-
Ben Assayag E, Shenhar-Tsarfaty S, Ofek K, Soreq L, Bova I, Shopin L, et al. Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality. Mol Med 2010; 16: 278-86.
-
(2010)
Mol Med
, vol.16
, pp. 278-286
-
-
Ben Assayag, E.1
Shenhar-Tsarfaty, S.2
Ofek, K.3
Soreq, L.4
Bova, I.5
Shopin, L.6
-
27
-
-
33644849003
-
Serum cholinesterase activity and proteosynthetic function of liver in patients with diabetes mellitus
-
Turecky TL, Kupcova V, Mojto V, Smuttny M, Uhlikova E, Vozar I. Serum cholinesterase activity and proteosynthetic function of liver in patients with diabetes mellitus. Bratisl Lek Listy 2005; 106: 266-9.
-
(2005)
Bratisl Lek Listy
, vol.106
, pp. 266-269
-
-
Turecky, T.L.1
Kupcova, V.2
Mojto, V.3
Smuttny, M.4
Uhlikova, E.5
Vozar, I.6
-
28
-
-
33646903923
-
Butyrylcholinesterase: Association with the metabolic syndrome and identification of 2 gene loci affecting activity
-
Valle A, O'Connor DT, Taylor P, Zhu G, Montgomery GW, Slagboom PE, et al. Butyrylcholinesterase: association with the metabolic syndrome and identification of 2 gene loci affecting activity. Clin Chem 2006; 52: 1014-20.
-
(2006)
Clin Chem
, vol.52
, pp. 1014-1020
-
-
Valle, A.1
O'Connor, D.T.2
Taylor, P.3
Zhu, G.4
Montgomery, G.W.5
Slagboom, P.E.6
-
29
-
-
79751528244
-
Vagus nerve stimulation as a strategy to prevent and manage metabolic syndrome
-
Das UN. Vagus nerve stimulation as a strategy to prevent and manage metabolic syndrome. Med Hypotheses 2011; 76: 429-33.
-
(2011)
Med Hypotheses
, vol.76
, pp. 429-433
-
-
Das, U.N.1
-
31
-
-
0022997997
-
Serum cholinesterase in patients with fatty liver
-
Nomura F, Ohnishi K, Koen H, Hiyama Y, Nakayama T, Itoh Y, et al. Serum cholinesterase in patients with fatty liver. J Clin Gastroenterol 1986; 8: 599-602.
-
(1986)
J Clin Gastroenterol
, vol.8
, pp. 599-602
-
-
Nomura, F.1
Ohnishi, K.2
Koen, H.3
Hiyama, Y.4
Nakayama, T.5
Itoh, Y.6
-
32
-
-
35448969267
-
Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance
-
Iwasaki T, Yoneda M, Nakajima A, Terauchi Y. Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance. Intern Med 2007; 46: 1633-39.
-
(2007)
Intern Med
, vol.46
, pp. 1633-1639
-
-
Iwasaki, T.1
Yoneda, M.2
Nakajima, A.3
Terauchi, Y.4
-
33
-
-
79952201422
-
Sonographic assessment of fatty liver using the measure ment of para-and perirenal fat thickness
-
Kawasaki S, Hasegawa O, Satoh S, Numata K, Terauchi Y. Sonographic assessment of fatty liver using the measure ment of para-and perirenal fat thickness. J Clin Ultrasound 2010; 38: 470-4.
-
(2010)
J Clin Ultrasound
, vol.38
, pp. 470-474
-
-
Kawasaki, S.1
Hasegawa, O.2
Satoh, S.3
Numata, K.4
Terauchi, Y.5
-
34
-
-
78649765012
-
High-sensitivity C-reactive protein and gamma-glutamyltransferase levels are synergistically associated with metabolic syndrome in community-dwelling persons
-
Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, et al. High-sensitivity C-reactive protein and gamma-glutamyltransferase levels are synergistically associated with metabolic syndrome in community-dwelling persons. Cardivasc Diabetol 2010; 9: 87.
-
(2010)
Cardivasc Diabetol
, vol.9
, pp. 87
-
-
Kawamoto, R.1
Tabara, Y.2
Kohara, K.3
Miki, T.4
Kusunoki, T.5
Takayama, S.6
-
35
-
-
53849123305
-
Association of serum gamma-glutamyltransferase with C-recative protein levels and white blood cell count in Korean adults
-
Lee YJ, Kim JK, Lee JH, Lee HR, Kang DR, Shim JY. Association of serum gamma-glutamyltransferase with C-recative protein levels and white blood cell count in Korean adults. Clin Chem Lab Med 2008; 46: 1410-5.
-
(2008)
Clin Chem Lab Med
, vol.46
, pp. 1410-1415
-
-
Lee, Y.J.1
Kim, J.K.2
Lee, J.H.3
Lee, H.R.4
Kang, D.R.5
Shim, J.Y.6
-
36
-
-
72549098792
-
Gamma-glutamyl transferase: A novel cardiovascular risk biomarker
-
Mason JE, Starke RD, Van Kirk JE. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol 2010; 13: 36-41.
-
(2010)
Prev Cardiol
, vol.13
, pp. 36-41
-
-
Mason, J.E.1
Starke, R.D.2
van Kirk, J.E.3
-
38
-
-
44949173227
-
Association between plasma alkaline phosphatase and C-reactive protein in Hong Kong Chinese
-
Cheung BMY, Ong KL, Cheung RV, Wong LYF, Wat NMS, Tam S et al. Association between plasma alkaline phosphatase and C-reactive protein in Hong Kong Chinese. Clin Chem Lab Med 2008; 46: 523-27.
-
(2008)
Clin Chem Lab Med
, vol.46
, pp. 523-527
-
-
Cheung, B.M.Y.1
Ong, K.L.2
Cheung, R.V.3
Wong, L.Y.F.4
Wat, N.M.S.5
Tam, S.6
-
39
-
-
76649129005
-
Association between serum alkaline phosphatise and C-reactive protein in the United Staes National Health and Nutrition Examination Survey 2005-2006
-
Webber M, Krishman A, Thomas NG, Cheung BMY. Association between serum alkaline phosphatise and C-reactive protein in the United Staes National Health and Nutrition Examination Survey 2005-2006. Clin Chem Lab Med 2010; 48: 167-73.
-
(2010)
Clin Chem Lab Med
, vol.48
, pp. 167-173
-
-
Webber, M.1
Krishman, A.2
Thomas, N.G.3
Cheung, B.M.Y.4
-
40
-
-
0031409592
-
Regulation of cytochrome P450 during inflammation and infection
-
Morgan ET. Regulation of cytochrome P450 during inflammation and infection. Drug Metab Rev 1997; 29: 1129-88.
-
(1997)
Drug Metab Rev
, vol.29
, pp. 1129-1188
-
-
Morgan, E.T.1
-
41
-
-
79954455540
-
A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid
-
Lampón N, Tutor JC. A preliminary investigation on the possible association between diminished copper availability and non-alcoholic fatty liver disease in epileptic patients treated with valproic acid. Upsala J Med Sci 2011; 116: 148-54.
-
(2011)
Upsala J Med Sci
, vol.116
, pp. 148-154
-
-
Lampón, N.1
Tutor, J.C.2
|